NCT05614596

Brief Summary

Identify the efficacy of difference procedures of imaging guidance for needles for interventional treatments of low back pain (LBP) associated with sciatica and to study results and satisfaction of the patients between different groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 14, 2022

Completed
17 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

10 months

First QC Date

October 14, 2022

Last Update Submit

November 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Control of pain by transforaminal epidural steroid injection combined with pulsed radio frequency guided by CT or fluoroscopy

    Interventional radiologists already possess the technical skills necessary to perform these interventions effectively. Pulsed radiofrequency is one of the interventional therapies for LBP, which uses radiofrequency alternating current to ablate the tissue around the needle electrode. Transforaminal epidural steroid injection (TFESI), as a minimally invasive interventional surgery, is widely used in the treatment of LBP. It has the advantages of less trauma, fewer complications, and faster onset. It relieves symptoms by injecting corticosteroids and local anesthetics around the dural and nerve roots that cause radicular pain. TFESI combined with PRF for the treatment of RLBP effectively and rapidly relieve radicular pain, reduce VAS (visual analog scale), relieve pain symptoms, improve the quality of life, cure rate, and satisfaction of patients, as well as, achieve long-term remission.

    Up to 4 weeks

Study Arms (2)

CT guided for patient with chronic low back pain

ACTIVE COMPARATOR

CT guided treatment in patients with low back pain

Other: CT guided and Flouroscopic guided injection of corticosteroid and local anathesia

Flouroscopic guided for patient wit chronic low back pain

ACTIVE COMPARATOR

Flouroscopic guided treatment in patients with low back pain

Other: CT guided and Flouroscopic guided injection of corticosteroid and local anathesia

Interventions

Patients will be grouped into two groups, the first group (Group A) included patients who were subjected to fluoroscopic guided injection, and the second group (Group B) will include patients who were subjected to CT guided injections.

CT guided for patient with chronic low back painFlouroscopic guided for patient wit chronic low back pain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with chronic radicular low back pain with unilateral or bilateral sciatica that persisted for more than 6 months and failed medical treatment for 6 weeks.
  • Pain exacerbates by leaning forward and flexion of the body with numbness and tingling in the legs.
  • Visual analog scale (VAS) of pain severity ≥ 5 related specifically to the daily LBP.
  • Patient develops calf and leg pain of leg raising test.
  • No neurological motor deficits

You may not qualify if:

  • Evidance of progressive motor neurological deficits.
  • Magnetic resonance imaging show evidence of \> 3 degenerated discs.
  • Intervertebral disc herniation ≥ 4 mm, disc sequestration, extrusion, disc space collapse or spondylolisthesis at the symptomatic level.
  • Moderate to severe central spinal canal or foraminal stenosis
  • Prior lumbar surgery of any kind at the same treatment level
  • Spinal fractures, deformities, infection or tumors.
  • History of uncontrolled coagulopathy or uncontrollable bleeding
  • Patients with psychotic illness, advanced hepatic, uncontrolled diabetic patients.
  • Current pregnancy, recent delivery (within 3-months of consent), or the intent of becoming pregnant during the study period.
  • Local sepsis or skin inflammatory in the back region.
  • Patients with red flags.
  • Neurologic findings (Fecal or urinary incontinence and cauda equina syndrome).
  • Persistent fever (infection).
  • Prolonged use of corticosteroids.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine

Asyut, 71511, Egypt

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Faculty Of Medicine

    Assiut University

    STUDY CHAIR

Central Study Contacts

Abd El-Rahman A. Omar, A. lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 14, 2022

First Posted

November 14, 2022

Study Start

December 1, 2022

Primary Completion

October 1, 2023

Study Completion

December 1, 2023

Last Updated

November 14, 2022

Record last verified: 2022-11

Locations